Therapeutic targets and delivery challenges for Alzheimer's disease
Therapeutic targets and delivery challenges for Alzheimer's disease作者机构:Department of Pharmaceutical Sciences and Technology Institute of Chemical Technology Department of Pharmacology Rajarambapu College of Pharmacy Tatyasaheb Kore College of Pharmacy
出 版 物:《World Journal of Pharmacology》 (世界药理学杂志)
年 卷 期:2015年第4卷第3期
页 面:236-264页
学科分类:1002[医学-临床医学] 100203[医学-老年医学] 10[医学]
主 题:Neurofbrillary tangles Alzheimer's disease Dementia Amyloid β Tau Neurodegeneration Blood brain barrier Transdermal Nasal
摘 要:Dementia, including Alzheimer’s disease, the 21^st Century epidemic, is one of the most signifcant social and health crises which has currently afficted nearly 44 million patients worldwide and about new 7.7 million cases are reported every year. This portrays the unmet need towards better understanding of Alzheimer’s disease pathomechanisms and related research towards more effective treatment strategies. The review thus comprehensively addresses Alzheimer’s disease pathophysiology with an insight of underlying multicascade pathway and elaborates possible therapeutic targets- particularly anti-amyloid approaches, anti-tau approaches, acetylcholinesterase inhibitors, glutamatergic system modifiers, immunotherapy, anti-nflammatory targets, antioxidants, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors and insulin. In spite of extensive research leading to identification of newer targets and potent drugs, complete cure of Alzheimer’s disease appears to be an unreached holy grail. This can be attributed to their ineffective delivery across blood brain barrier and ultimately to the brain. With this understanding, researchers are now focusing on development of drug delivery systems to be delivered via suitable route that can circumvent blood brain barrier effectively with enhanced patient compliance. In this context, we have summarized current drug delivery strategies by oral, transdermal, intravenous, intranasal and other miscellaneous routes and have accentuated the future standpoint towards promising therapy ultimately eading to Alzheimer’s disease cure.